Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Quantum-Si Inc | 1,732,582 | reported | 21 Apr 2026 | tx 18+4,630,470−117,041 |
| DIGIRAD CORP | 33,493 | reported | 28 Feb 2018 | tx 39+460,037−59,098 |
| CNS Pharmaceuticals, Inc. | 1,517 | reported | 17 Nov 2025 | tx 8+234,612 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Apr 2026 | SALE | Quantum-Si Inc | 37,382 | 1.01 USD | |
| 21 Apr 2026 | SALE | Quantum-Si Inc | 37,381 | 0.99 USD | |
| 20 Mar 2026 | SALE | Quantum-Si Inc | 4,233 | 0.85 USD | |
| 23 Mar 2026 | SALE | Quantum-Si Inc | 4,422 | 0.83 USD | |
| 12 Mar 2026 | GRANT_AWARD | Quantum-Si Inc | 652,803 | 0.00 USD | |
| 12 Mar 2026 | GRANT_AWARD | Quantum-Si Inc | 780,847 | 0.00 USD | deriv |
| 22 Dec 2025 | SALE | Quantum-Si Inc | 8,627 | 1.28 USD | |
| 17 Nov 2025 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 1,517 | 0.00 USD | deriv |
| 23 Sept 2025 | SALE | Quantum-Si Inc | 3,873 | 1.64 USD | |
| 22 Sept 2025 | SALE | Quantum-Si Inc | 3,873 | 1.68 USD | |
| 23 Jun 2025 | SALE | Quantum-Si Inc | 8,624 | 1.61 USD | |
| 21 Mar 2025 | SALE | Quantum-Si Inc | 8,626 | 1.39 USD | |
| 12 Mar 2025 | GRANT_AWARD | Quantum-Si Inc | 750,000 | 0.00 USD | |
| 09 Aug 2024 | PURCHASE | Quantum-Si Inc | 50,000 | 0.87 USD | |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 15 Mar 2024 | GRANT_AWARD | Quantum-Si Inc | 346,820 | 0.00 USD | |
| 05 Mar 2024 | PURCHASE | Quantum-Si Inc | 50,000 | 1.61 USD | first after silenceanomaly |
| 21 Sept 2023 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 68,961 | — | deriv |
| 15 May 2023 | GRANT_AWARD | Quantum-Si Inc | 500,000 | 0.00 USD | deriv |
| 15 May 2023 | GRANT_AWARD | Quantum-Si Inc | 500,000 | 0.00 USD | deriv |
| 15 May 2023 | GRANT_AWARD | Quantum-Si Inc | 1,000,000 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 11,100 | 0.30 USD | |
| 15 Jul 2021 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 32,000 | — | deriv |
| 12 Jun 2020 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 46,559 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 05 Mar 2024.